Sugarloaf Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Sugarloaf Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-72	Closed	-$2.18K	–	695
2023 Q1	$2.18K	Hold	72	–	–	﹤0.01%	611
2022 Q4	$2.04K	Sell	72 -1	-1%	-$32	﹤0.01%	673
2022 Q3	$3K	Sell	73 -60	-45%	-$2.2K	﹤0.01%	661
2022 Q2	$4K	Hold	133	–	–	﹤0.01%	622
2022 Q1	$6K	Buy	133 +61	+85%	+$2.91K	﹤0.01%	541
2021 Q4	$4K	Hold	72	–	–	﹤0.01%	607
2021 Q3	$5K	Sell	72 -250	-78%	-$21K	﹤0.01%	600
2021 Q2	$30K	Sell	322 -390	-55%	-$33.2K	0.01%	352
2021 Q1	$54	Buy	+712	New	+$70.6K	0.02%	259

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Sugarloaf Wealth Management's ARKG Position: Q2 2023 in Review

Sugarloaf Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2023, closing a stake of 72 shares — an estimated $2.18K sold.

Sugarloaf Wealth Management first reported a position in ARKG in Q1 2021 and held it in 9 quarters. The position peaked at $30K in Q2 2021. 290 funds tracked by Wall St. Rank hold ARKG as of Q2 2023.

Sugarloaf Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2023 after selling out during the quarter.
Sugarloaf Wealth Management sold 72 ARK Genomic Revolution ETF shares in Q2 2023, an estimated $2.18K.
Sugarloaf Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 9 quarters.
Sugarloaf Wealth Management's ARK Genomic Revolution ETF position peaked at $30K in Q2 2021.
290 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2023.

Based on Sugarloaf Wealth Management's 13F filing for Q2 2023, filed 13 Jul 2023.